Nu Skin Enterprises, Inc.NUS

NYSEHealthcareWholesale-Drugs, Proprietaries & Druggists' Sundries
Price (close)
$4.62
Market cap
$224.9M
P/E
—
Revenue (TTM)
$1.4B
Net income
-$216.4M
Dividend yield
5.19%
1-year total return
-60.1%
Net margin
-15.7%
Revenue growth
-15.4%
Debt / equity
0.39x

What Nu Skin Enterprises, Inc. does.

Nu Skin Enterprises, Inc. develops and distributes a comprehensive line of premium-quality beauty and wellness solutions in nearly 50 markets worldwide. In 2025, our revenue of

$1.5 billion was primarily generated by our two primary product categories: beauty products and wellness products. We operate in the direct selling channel, primarily utilizing person-to-person

synergistic and adjacent growth through our strategic investment arm known as Rhyz Inc., which we formed in 2018. Our Rhyz businesses primarily consist of consumer, technology and manufacturing companies. In 2025, the Rhyz companies generated

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue$2.6B$2.7B$2.2B$2.0B$1.7B$1.5B
Net income$191.4M$147.3M$104.8M$8.6M-$146.6M$160.2M
Free cash flow$315.3M$73.0M$49.0M$60.1M$70.2M$46.0M

More on NUS.

Figures from Nu Skin Enterprises, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.